Inter‐ and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma-Reference-Cited by-同舟云学术

Inter‐ and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma

Published:2019-09-09 Issue:2 Volume:76 Page:191-200
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Downes Michelle R¹²^ORCID,Slodkowska Elzbieta¹²,Katabi Nora³,Jungbluth Achim A³,Xu Bin³^ORCID

Affiliation:

1. Department of Laboratory Medicine and Molecular Diagnostics Sunnybrook Health Sciences Centre Toronto ON Canada

2. Department of Laboratory Medicine and Pathobiology University of Toronto Toronto ON Canada

3. Dpartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.13946

Reference40 articles.

1. Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer

2. A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now

3. Genomics- and Transcriptomics-Based Patient Selection for Cancer Treatment With Immune Checkpoint Inhibitors

4. Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians

5. Emerging Role of Immunotherapy in Advanced Urothelial Carcinoma

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 Expression and Its Association With p16 in Head and Neck Squamous Cell Carcinoma in Southwestern Uganda;Pathology and Laboratory Medicine International;2024-04

2. Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institutional Study on Comparison of Manual and Artificial Intelligence Measurement Model (AIM-PD-L1) Pathology Assessments;Virchows Archiv;2024-04

3. An artificial intelligence‐powered PD‐L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability;Histopathology;2024-03-13

4. Programmed Cell Death Ligand 1 Immunoexpression in Head and Neck Squamous Cell Carcinoma: A Narrative Review of Considerations for the Histopathologist;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024

5. Immunohistochemical study of Programmed Cell Death Ligand 1 (PDL1) expression by combined positive score using 22C3 clone in head and neck squamous cell carcinomas, its correlation with clinicopathological features and outcome;Journal of Oral and Maxillofacial Pathology;2024-01